RTI Surgical
Gamma Medica closes $18M Series A round | Wall Street Beat
Gamma Medica said it’s closed a $16 million Series A round from Psilos Group Managers.
The Northridge, Calif.-based company said it plans to use the cash to expand the commercial footprint of its LumaGen molecular breast imaging device and the LumaGuide biopsy model.
RTI Biologics nabs Pioneer Surgical in $130M deal
RTI Biologics (NSDQ:RTIX) hopes a $130-million acquisition of Pioneer Surgical will help strengthen distribution and allow the company to expand into metal and synthetic implants. RTI today announced its intent to acquire Pioneer in a cash deal to acquire all of Pioneer’s outstanding stock.
Zimmer slides on Q1 results | Earnings Roundup
Entegrion licenses clotting bandage to Boston device firm
For its 9th birthday, the biotech Entegrion is giving itself a present: a product on the market.
The Research Triangle Park, N.C.-based company struck a licensing deal with a Boston-based medical device company to manufacture and market Entegrion’s Stasilon bandage: a proprietary weave of glass and bamboo fibers that promotes clotting. CTO Joseph DaCorta wouldn’t name the company Beantown partner, but DaCorta did say that the business expects to make an announcement this week.
Life rides sales growth to 45 percent profit increase | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Athersys inks $40 million licensing deal with orthopedic implant maker
Athersys Inc. (NSDQ:ATHX) licensed its stem cell technology to a Florida firm that makes orthopedic implants in a deal that could be worth more than $40 million.
RTI Biologics swings to Q4 black
RTI Biologics Inc. (NSDQ:RTIX) posted fourth-quarter sales of $42 million for the three months ended Dec. 31, 2009, up 12 percent compared with $37.4 million during the same period in 2008. Net income was $1.5 million, compared with a net loss of $102.5 million during Q4 2008: